Metraipolis › archive › dc_7e73b169bebc
An in silico VAR2CSA-based multi-epitope vaccine candidate (PM-MEV-k1) shows favourable Structural and Immune Simulation parameters for protection against… — Europe PMC PPR:PPR1323029
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR1323029
- DOI
- 10.21203/rs.3.rs-10820730/v1
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T14:51:49.513Z
- SHA-256 of the archived text
e1303848c24dd30aab16c6354a2c6c4db632288d5bc2c3b41b683165a513dd66- Stable URL of this page
https://metraipolis.com/documento/dc_7e73b169bebc
How to cite
An in silico VAR2CSA-based multi-epitope vaccine candidate (PM-MEV-k1) shows favourable Structural and Immune Simulation parameters for protection against… — Europe PMC PPR:PPR1323029 — Europe PMC, https://europepmc.org/article/PPR/PPR1323029 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e73b169bebc (Metraipolis archive dc_7e73b169bebc, sha256 e1303848c24dd30aab16c6354a2c6c4db632288d5bc2c3b41b683165a513dd66)
BibTeX
@misc{dc7e73b169bebc,
title = {An in silico VAR2CSA-based multi-epitope vaccine candidate (PM-MEV-k1) shows favourable Structural and Immune Simulation parameters for protection against… — Europe PMC PPR:PPR1323029},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR1323029},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e73b169bebc; sha256 e1303848c24dd30aab16c6354a2c6c4db632288d5bc2c3b41b683165a513dd66},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1323029. Agents can read the archived copy with the MCP tool read_document.